IMARC Group, a leading market research company, has recently releases report titled “Drug Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global drug screening market size, growth, share, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Industry Overview of Drug Screening
Drug screening involves the collection and analysis of an individual's blood, urine, hair, or saliva to identify contaminants and chemicals resulting from drug use. Various testing methods, including liquid chromatography/mass spectrometry (LC/MS), enzyme immunoassays (IAs), and gas chromatography (GC), are utilized for accurate drug confirmation following initial positive results. Its purpose is to detect the misuse of drugs, encompassing illegal substances like cocaine, heroin, and MDMA, as well as the misuse of prescription medications through altered administration or excessive dosages. Drug screening is integral to clinical trials for assessing the effectiveness and safety of novel drugs, as well as during legal proceedings for law enforcement purposes. Additionally, it aids in evaluating abuse potential and adherence among patients undergoing opioid therapy.
How Big Is the Drug Screening Market?
The global drug screening market size reached US$ 6.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028.
Request Sample Copy of This Report: https://www.imarcgroup.com/drug-screening-market/requestsample
What are the growth prospects and trends in the drug screening industry?
The current market is positively influenced by the heightened demand for drug screening, driven by its accuracy and prompt results. Furthermore, the market is experiencing growth due to the escalating prevalence of substance abuse worldwide. Moreover, the market outlook is favorable due to the increasing use of drugs by the general population to cope with losses, stress, and anxiety.
Additionally, the market is boosted by the rising trend of clubbing, alcohol consumption, smoking, and drug use among young individuals influenced by peer pressure. Moreover, government agencies in various countries are implementing regular roadside oral fluid screening to identify drug-impaired drivers, along with launching programs addressing substance abuse and addiction.
Furthermore, the market is supported by the rise in drug traffickers and local dealers facilitating easy access to drugs for addicts. This is compounded by the growing utilization of virtual currencies operating outside the traditional financial system, providing enhanced anonymity for drug dealers and buyers worldwide.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product and Service:
- Equipment
o Immunoassay Analyzers
o Chromatography Instruments
o Breath Analyzers
- Rapid Testing Devices
o Urine Testing Devices
o Oral Fluid Testing Devices
- Consumables
o Assay Kits
o Sample Collection Cups
o Calibrators and Controls
o Others
- Laboratory Services
Breakup by Sample Type:
- Urine Samples
- Breath Samples
- Oral Fluid Samples
- Hair Samples
- Others
Breakup by End User:
- Hospitals
- Drug Testing Laboratories
- Workplaces
- Drug Treatment Centers
- Pain Management Centers
- Personal Users
- Criminal Justice System and Law Enforcement Agencies
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc., Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG, Thermo Fisher Scientific Inc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
English